JP2015528509A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015528509A5 JP2015528509A5 JP2015532108A JP2015532108A JP2015528509A5 JP 2015528509 A5 JP2015528509 A5 JP 2015528509A5 JP 2015532108 A JP2015532108 A JP 2015532108A JP 2015532108 A JP2015532108 A JP 2015532108A JP 2015528509 A5 JP2015528509 A5 JP 2015528509A5
- Authority
- JP
- Japan
- Prior art keywords
- integer
- composition
- moiety
- eye
- sulfonate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000412 dendrimer Substances 0.000 claims description 18
- 229920000736 dendritic polymer Polymers 0.000 claims description 18
- 229920002521 macromolecule Polymers 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 9
- 208000015181 infectious disease Diseases 0.000 claims description 7
- 206010010741 Conjunctivitis Diseases 0.000 claims description 6
- 150000003871 sulfonates Chemical class 0.000 claims description 6
- 150000003460 sulfonic acids Chemical class 0.000 claims description 6
- 208000035143 Bacterial infection Diseases 0.000 claims description 5
- 208000036142 Viral infection Diseases 0.000 claims description 5
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 5
- 230000003612 virological effect Effects 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims 19
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 11
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims 11
- 108010039918 Polylysine Proteins 0.000 claims 7
- 229920000656 polylysine Polymers 0.000 claims 7
- 230000000813 microbial effect Effects 0.000 claims 6
- 241000701161 unidentified adenovirus Species 0.000 claims 4
- 206010010755 Conjunctivitis viral Diseases 0.000 claims 3
- 208000005914 Viral Conjunctivitis Diseases 0.000 claims 3
- 239000000882 contact lens solution Substances 0.000 claims 3
- 125000003277 amino group Chemical group 0.000 claims 2
- 201000007032 bacterial conjunctivitis Diseases 0.000 claims 2
- 230000001954 sterilising effect Effects 0.000 claims 2
- 238000004659 sterilization and disinfection Methods 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 208000034579 Acute haemorrhagic conjunctivitis Diseases 0.000 claims 1
- 206010001257 Adenoviral conjunctivitis Diseases 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 241000606161 Chlamydia Species 0.000 claims 1
- 241000606790 Haemophilus Species 0.000 claims 1
- 241000588653 Neisseria Species 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 206010034960 Photophobia Diseases 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 claims 1
- 241000589516 Pseudomonas Species 0.000 claims 1
- 241000191940 Staphylococcus Species 0.000 claims 1
- 241000194017 Streptococcus Species 0.000 claims 1
- 206010042674 Swelling Diseases 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 206010047571 Visual impairment Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000021373 epidemic keratoconjunctivitis Diseases 0.000 claims 1
- 201000001371 inclusion conjunctivitis Diseases 0.000 claims 1
- 230000007794 irritation Effects 0.000 claims 1
- 230000007803 itching Effects 0.000 claims 1
- 206010023332 keratitis Diseases 0.000 claims 1
- 201000010666 keratoconjunctivitis Diseases 0.000 claims 1
- 230000036407 pain Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 201000006476 shipyard eye Diseases 0.000 claims 1
- 230000008961 swelling Effects 0.000 claims 1
- 241001529453 unidentified herpesvirus Species 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
- 208000029257 vision disease Diseases 0.000 claims 1
- 230000004393 visual impairment Effects 0.000 claims 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Cc1ccccc1 Chemical compound Cc1ccccc1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 7
- HJSJTXDVLAQOMA-UHFFFAOYSA-N CCCC(NC(C)(C)CS(O)(=O)=O)=O Chemical compound CCCC(NC(C)(C)CS(O)(=O)=O)=O HJSJTXDVLAQOMA-UHFFFAOYSA-N 0.000 description 5
- ZVZNQZHTMBIDJH-UHFFFAOYSA-N CC(CCC(NCC[S](C)(O)(=O)=O)=O)=O Chemical compound CC(CCC(NCC[S](C)(O)(=O)=O)=O)=O ZVZNQZHTMBIDJH-UHFFFAOYSA-N 0.000 description 3
- QPUYECUOLPXSFR-UHFFFAOYSA-N Cc1c(cccc2)c2ccc1 Chemical compound Cc1c(cccc2)c2ccc1 QPUYECUOLPXSFR-UHFFFAOYSA-N 0.000 description 3
- KWHYAIHZUQICHA-UHFFFAOYSA-N CC(CCC(NCCS(O)(=O)=O)=O)=O Chemical compound CC(CCC(NCCS(O)(=O)=O)=O)=O KWHYAIHZUQICHA-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- DNLDMOAFPACEFD-UHFFFAOYSA-N CC(C)(CS(O)(=O)=O)NC(CC=C)=O Chemical compound CC(C)(CS(O)(=O)=O)NC(CC=C)=O DNLDMOAFPACEFD-UHFFFAOYSA-N 0.000 description 1
- JJFZQNVFWVBLTQ-UHFFFAOYSA-N CCCC(NC(C)(C)CS(O)(=O)=O)=C Chemical compound CCCC(NC(C)(C)CS(O)(=O)=O)=C JJFZQNVFWVBLTQ-UHFFFAOYSA-N 0.000 description 1
- AKCVWFRALJPANX-UHFFFAOYSA-N CCCCC(NCCC)=O Chemical compound CCCCC(NCCC)=O AKCVWFRALJPANX-UHFFFAOYSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261700714P | 2012-09-13 | 2012-09-13 | |
| US61/700,714 | 2012-09-13 | ||
| PCT/US2013/059810 WO2014043576A1 (en) | 2012-09-13 | 2013-09-13 | Method of treatment or prophylaxis of infections of the eye |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018191652A Division JP6766114B2 (ja) | 2012-09-13 | 2018-10-10 | 眼の感染症の治療または予防方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015528509A JP2015528509A (ja) | 2015-09-28 |
| JP2015528509A5 true JP2015528509A5 (https=) | 2018-01-11 |
| JP6419701B2 JP6419701B2 (ja) | 2018-11-07 |
Family
ID=50278734
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015532108A Active JP6419701B2 (ja) | 2012-09-13 | 2013-09-13 | 眼の感染症の治療または予防方法 |
| JP2018191652A Active JP6766114B2 (ja) | 2012-09-13 | 2018-10-10 | 眼の感染症の治療または予防方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018191652A Active JP6766114B2 (ja) | 2012-09-13 | 2018-10-10 | 眼の感染症の治療または予防方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10149885B2 (https=) |
| EP (1) | EP2895161B1 (https=) |
| JP (2) | JP6419701B2 (https=) |
| CN (2) | CN108452316B (https=) |
| CA (1) | CA2884897C (https=) |
| DK (1) | DK2895161T3 (https=) |
| ES (1) | ES2633778T3 (https=) |
| IN (1) | IN2015DN02233A (https=) |
| WO (1) | WO2014043576A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009008006A2 (en) * | 2007-07-06 | 2009-01-15 | Lupin Limited | Pharmaceutical compositions for gastrointestinal drug delivery |
| RU2667118C1 (ru) * | 2017-11-15 | 2018-09-14 | Федеральное государственное бюджетное научное учреждение "Прикаспийский зональный научно-исследовательский ветеринарный институт" | Универсальное средство в виде мази для комплексного лечения глазных болезней животных и способ его получения |
| CN110664757B (zh) * | 2018-11-19 | 2022-08-02 | 成都瑞沐生物医药科技有限公司 | 纳米晶滴眼剂、其制备方法及其应用 |
| GB2599799B (en) * | 2020-04-15 | 2023-04-05 | Starpharma Pty Ltd | Macromolecule for prophylaxis of Coronavirus |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPM623994A0 (en) * | 1994-06-15 | 1994-07-07 | Biomolecular Research Institute Limited | Antiviral dendrimers |
| DE69927380T2 (de) * | 1998-07-14 | 2006-07-06 | Pharmacia & Upjohn Co. Llc, Kalamazoo | Oxazolidinone zur behandlung von augeninfektionen |
| AUPP584298A0 (en) | 1998-09-14 | 1998-10-08 | Starpharma Limited | Antimicrobial and antiparasitic agents |
| AUPR412801A0 (en) * | 2001-03-30 | 2001-05-03 | Starpharma Limited | Agent for the prevention and treatment of sexually transmitted disease s - I |
| WO2005007223A2 (en) * | 2003-07-16 | 2005-01-27 | Sasha John | Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations |
| PL1755616T3 (pl) | 2004-04-08 | 2014-10-31 | Eye Co Pty Ltd | Leczenie mineralokortykoidami retinopatii wysiękowej |
| PL1937284T3 (pl) * | 2005-10-18 | 2016-05-31 | Starpharma Pty Ltd | System podawania kompozycji bakteriobójczego dendymeru |
| ES2625109T3 (es) * | 2005-10-25 | 2017-07-18 | Starpharma Pty Limited | Compuestos macromoleculares que tienen estequiometría controlada |
| WO2007137369A1 (en) * | 2006-05-31 | 2007-12-06 | Medihoney Pty Ltd | Medicinal compositions containing honey |
| PL2214646T3 (pl) | 2007-10-05 | 2021-12-20 | Wayne State University | Dendrymery do przedłużonego uwalniania związków |
| WO2010096558A1 (en) * | 2009-02-18 | 2010-08-26 | Eyeon Particle Sciences Llc | Bi-functional co-polymer use for ophthalmic and other topical and local applications |
| MY155507A (en) * | 2009-07-07 | 2015-10-30 | Adenovir Pharma Ab | Antiviral compounds |
| KR20180126621A (ko) | 2011-05-16 | 2018-11-27 | 스타파마 피티와이 리미티드 | 세균성 질염의 치료 또는 예방 방법 |
-
2013
- 2013-09-13 JP JP2015532108A patent/JP6419701B2/ja active Active
- 2013-09-13 EP EP13837849.2A patent/EP2895161B1/en active Active
- 2013-09-13 CN CN201810557127.1A patent/CN108452316B/zh active Active
- 2013-09-13 IN IN2233DEN2015 patent/IN2015DN02233A/en unknown
- 2013-09-13 WO PCT/US2013/059810 patent/WO2014043576A1/en not_active Ceased
- 2013-09-13 DK DK13837849.2T patent/DK2895161T3/en active
- 2013-09-13 CA CA2884897A patent/CA2884897C/en active Active
- 2013-09-13 ES ES13837849.2T patent/ES2633778T3/es active Active
- 2013-09-13 US US14/427,970 patent/US10149885B2/en active Active
- 2013-09-13 CN CN201380059141.4A patent/CN105007910B/zh active Active
-
2018
- 2018-10-10 JP JP2018191652A patent/JP6766114B2/ja active Active
- 2018-11-02 US US16/179,384 patent/US11219691B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pandey et al. | Potential of stimuli-responsive in situ gel system for sustained ocular drug delivery: Recent progress and contemporary research | |
| TWI624263B (zh) | 胺官能性聚醯胺 | |
| ES2856831T3 (es) | Una composición que comprende un antibiótico no peptídico y cisteamina | |
| ES2394130T3 (es) | Composiciones y métodos para tratar infecciones vaginales y biopelículas vaginales patógenas | |
| US11351191B2 (en) | Silicate containing compositions and methods of treatment | |
| AU2016371598B2 (en) | Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation | |
| JP2014516954A5 (https=) | ||
| JP2015528509A5 (https=) | ||
| TW201143783A (en) | Non-irritating ophthalmic povidone-iodine compositions | |
| RU2018142943A (ru) | Композиции для лечения нарушений кислотно-основного равновесия | |
| CN105246457B (zh) | 局部氨苯砜和氨苯砜/阿达帕林组合物及其使用方法 | |
| ES2449340T3 (es) | Compuestos calcimiméticos para su uso en el tratamiento de trastornos intestinales | |
| KR20130121893A (ko) | 염증 관련 장애의 치료 및 예방에 사용하기 위한 조성물 | |
| CA3019769C (en) | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa | |
| JP2018516866A (ja) | マイコバクテリア感染症及び肺疾患を治療するための組成物及び方法 | |
| JP2019511496A5 (https=) | ||
| CN103687601B (zh) | 治疗或预防细菌性阴道病的方法 | |
| JP6766114B2 (ja) | 眼の感染症の治療または予防方法 | |
| JP2012526099A5 (https=) | ||
| JP2010506855A5 (https=) | ||
| Liu et al. | Designer amphiphilic helical peptide-decorated nanomicelles enable simultaneous inflammation control and triple-destruction of bacteria for treating bacterial pneumonia and sepsis | |
| TWI482632B (zh) | 醫藥用載體及使用該載體的藥物結構 | |
| WO2016020408A2 (en) | Compounds for preventing ototoxicity | |
| US20050227949A1 (en) | Compositions and methods for treatment of viral and bacterial infections | |
| JP2011121983A (ja) | 粘膜の疾患および障害の予防および処置のための液体製剤 |